People with absorption issues may need higher-dose products to see any effect, which adds up over time
Selective NNMT inhibitor substrate site-targeting mechanism with IC50 of 1.2 M in reference assay conditions Selectivity over related methyltransferases does not significantly affect other enzymes in the NAD salvage pathway at research concentrations Reduces intracellular 1-methylnicotinamide (1-MNA) formation in cell-based assay models Studied in adipocyte, liver, and skeletal muscle cell-based research models examining NNMT-dependent methylation pathway dynamics Referenced at Sigma-Aldrich (SML2832) and in peer-reviewed literature on NNMT enzyme biology Membrane-permeable quaternary quinolinium scaffold studied for intracellular NNMT target engagement in cell-based models Batch and lot identifiers on all labeling for full laboratory documentation compliance Research Background 5-Amino-1MQ was first characterized as a selective NNMT inhibitor in published research literature in 2018
Keep a fresh, batch-matched COA on hand
While most individuals obtain sufficient amounts of vitamin B12 through their diet, some individuals may require supplementation due to certain health conditions or lifestyle choices that can lead to vitamin B12 deficiency
High Dosage Injections typically provide a much higher dose of Vitamin B12 compared to oral supplements
A COA documents third-party testing of the medication for: Identity (confirming the medication is what the label says) Potency (confirming the concentration matches the label) Sterility (confirming no microbial contamination) Endotoxin levels (confirming safety for injection) pH and stability If your pharmacy cannot or will not provide a COA, consider whether you are comfortable using their products
